期刊文献+

恶性黑色素瘤干细胞的研究进展 被引量:4

下载PDF
导出
摘要 恶性黑色素瘤是起源于神经嵴的黑素细胞的高度恶性肿瘤,其发生率占体表恶性肿瘤的7%--20%。其特点表现为恶性程度高、易转移、预后差和对放化疗均不敏感[1]。转移性恶性黑色素瘤中位生存期仅6个月,5年生存率不足5%[2]。近年来随着对肿瘤研究的不断进展,提出了肿瘤干细胞(tumor stem cells)学说[3],该学说认为肿瘤细胞具有异质性,同一肿瘤中,大部分的细胞已经失去了生长分化潜能,只有一小部分细胞具有无限增殖、分化和体外克隆的潜力,由于其具有干细胞特性,故称其为肿瘤干细胞,它不仅是肿瘤群体的起源细胞,也维持整个瘤群的更新和生长。
出处 《广东医学》 CAS CSCD 北大核心 2014年第22期3591-3594,共4页 Guangdong Medical Journal
基金 江西省科技支撑计划项目(编号:2010BSA14600)
  • 相关文献

参考文献7

二级参考文献141

  • 1Shi-YingZheng,De-ChunLi,Zhi-DeZhang,JunZhao,Jin-FengGe.Adenovirus-mediated FasL gene transfer into human gastric carcinoma[J].World Journal of Gastroenterology,2005,11(22):3446-3450. 被引量:5
  • 2杜标炎,袁静,谭宇蕙,吴映雅,张立群,李杰芬,罗惠,易华.六味地黄丸对自杀基因系统治疗黑色素瘤的增效作用[J].广州中医药大学学报,2006,23(5):397-402. 被引量:8
  • 3安丽娜,李著华,岳扬,王树人,郭志英,彭克军.婴儿双歧杆菌介导的CD和UPRT联合5-FC基因疗法对黑色素瘤的体外治疗实验研究[J].四川大学学报(医学版),2007,38(1):27-30. 被引量:12
  • 4[1]Atkins MB.Immunotherapy and experimental approaches for metastatic melanoma[J].Hematol Oncol Clin North Am,1998,12:877-902, viii.
  • 5[2]Gane E, Saliba F,Valdecasas GJ, et al.Randomized trial of efficacy and safety of oral ganciclovir in the prevention of cytomegalovirus disease in liver-transplant recipients:the Oral Ganciclovir International Transplantation Study Group [corrected][J].Lancet,1997,350:1729-1733.
  • 6[3]Klatzmann D, Cherin P, Bensimon G, et al.A phase I/II dose-escalation study of herpes simplex virus type 1 thymidine kinase "suicide" gene therapy for metastatic melanoma.Study Group on Gene Therapy of Metastatic Melanoma[J].Hum Gene Ther,1998,9:2585-2594.
  • 7[4]Bonnekoh B, Greenhalgh DA, Bundman DS, et al.Adenoviral mediated herpes simplex virus-thymidine kinase gene transfer in vivo for treatment of experimental human melanoma[J].J Invest Dermatol,1996,106:1163-1168.
  • 8[5]Schneeberger A,Goos M,Stingl G, et al.Management of malignant melanoma:new developments in immune and gene therapy[J].Clin Exp Dermatol,2000,25:509-519.
  • 9[6]Dummer R, Bergh J, Karlsson Y, et al.Biological activity and safety of adenoviral vector-expressed wild-type p53 after intratumoral injection in melanoma and breast cancer patients with p53-overexpressing tumors[J].Cancer Gene Ther,2000,7:1069-1076.
  • 10[7]Castellano M, Parmiani G.Genes involved in melanoma:an overview of INK4a and other loci[J].Melanoma Res,1999,9:421-432.

共引文献51

同被引文献55

  • 1李霄,金宁一,米志强,连海,孙迎春,李杰,管国芳.联合应用凋亡素基因、新城疫病毒HN基因及IL-18基因对黑色素瘤的抑制效应研究[J].高技术通讯,2004,14(12):33-36. 被引量:8
  • 2田蓉,程绍辉,于继云,李巍,刘玉峰.对小鼠黑色素瘤细胞肺转移的抑制作用mGM-CSF基因转染[J].第四军医大学学报,2006,27(6):484-486. 被引量:1
  • 3秦迎松,张旭,李俐,于红丽.组胺对C57BL/6小鼠B16黑色素瘤转移行为的影响[J].癌症,2007,26(8):833-836. 被引量:1
  • 4汪向东,王希林,马弘,等.心理卫生评定量表手册[M].北京:中国心理卫生杂志社,1999.
  • 5Canpolat M, G6khan AG, Ciftcioglu MA,et al. Dif- ferentiation of melanoma from non-cancerous tissue in an animal model using elastic light single-scatter- ing spectroscopy[J]. Technol Cancer Res Treat, 2008,7 (3) : 235 -- 240.
  • 6Fidler IJ. Critical factors in the biology of human cancer metastasis: Twenty eight G. H. A. Clowes memorial award lecture [J]. Cancer Res, 1990,50 (23) :6130--6138.
  • 7E1-Khattouti A, Selimovic D, Ha'fkel Y, et al. Identification and analysis of CD133 melanoma stem-like cells conferring resistance to taxol:an insight into the mechanisms of their resistance and response[ J]. Cancer Lett, 2014, 343:123-133.
  • 8Sosman JA, Kim KB, Schuchter L, et al. Survival in BRAF V600-mutant advanced melanoma treated with vemurafenib [ J ]. N Eng J Med, 2012, 366 : 707- 714.
  • 9Schroevers M J, Helgeson VS,Sanderman R, et al. Type of social support matters for prediction of posttraumatic growth among cancer survivors[ J]. Psychooncology, 2010, 19:46-53.
  • 10Schulenburg A,Blatt K,Cerny-Reiterer S,et al.Cancer stem cells in basic science and in translational oncology:can we translate into clinical application[J],J Hematol Oncol,2015,8:pi6.

引证文献4

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部